AseBio Report

The AseBio Report, published every year by the Spanish Bioindustry Association since 2003, is the benchmark publication for the Spanish biotechnology sector.
The report includes the main statistical data on how the sector is evolving, compiled by the INE (Spanish Statistical Office) and analyzed by AseBio. It also has information on production (pipelines) and technology transfer (patents) for Spanish biotechnology companies and on investment in the sector.
AseBio Report 2022

The AseBio 2022 Report shows a return to pre-pandemic growth levels after an exceptional period.

portada informe
AseBio Report 2021

In 2021, AseBio wanted to share the value of the biotech industry as a strategic sector for the economic and social transformation of Spain by 2050 and its impact on the new agenda for sustainable growth. 

AseBio Report 2020
AseBio Report 2020

The AseBio 2020 Report shows the great leap of Spanish biotechnology in the year of the pandemic.


AseBio Report 2019
AseBio Report 2019

In 2018, the biotechnology sector invested nearly €770 million in R&D, 71% from biotech companies.

Portada Informe Asebio 2018
Asebio Report 2018

Biotechnology companies have had an impact on the Spanish economy of almost 7,000 million euros (0.7% of GDP) and have generated 92,384 jobs.

Informe Asebio 2017
Asebio Report 2017

In 2017, financial operations in the Spanish biotechnology sector reached 149 million euros.

Informe Asebio 2016
Asebio Report 2016

This edition of the annual report introduces a new methodology for calculating the economic impact of the sector.

Informe Asebio 2015
Asebio Report 2015

The data in this report shows that most of the ratios in the sector have grown: turnover, employment, investment in R&D.

Informe Asebio 2014
Asebio Report 2014

In 2013 the sector has perceived the crisis, with a decrease in the number of biotech companies and companies with biotechnological activities.

Informe Asebio 2013
Informe Asebio 2013

The latest advances in molecular biology have allowed us to identify a whole series of biomarkers that have meant a very significant improvement in the diagnosis and prognosis of diseases.

Informe Asebio 2012
Informe Asebio 2012

During 2012 the ASEBIO associated entities had launch a total of 132 products or services; 94 were direct to the field of human health, 30 to the agri-food field, 18 were industrial processes and 16 to animal health.

Informe Asebio 2011
Asebio Report 2011

In 2011, a total of 112 alliances were registered, 63% were carried out with another biotech company, 46% with public entities and 38% with a user company.

Informe Asebio 2010
Asebio Report 2010

In 2009 the national biotech sector reached 1,095 companies with activities in biotechnology, of which 399 are dedicated exclusively to biotechnology. The personnel employed amounted to 148,648 and the turnover to € 53,152 MM.

Informe Asebio 2009
Asebio Report 2009

Despite the economic crisis, in 2008 the biotechnology sector had a turnover of more than 31,100 million euros and employed 108,374 people, with year-on-year growth of 18.9 and 4.3% respectively.

Informe Asebio 2008
Asebio Report 2008

Approximately 30% of ASEBIO companies exported a total of € 108 MM. Spanish biotech companies export both products and services linked to R&D, especially in the area of ​​Biomedicine and with a certain presence in the agri-food sector.

Informe Asebio 2007
Asebio Report 2007

659 companies that carry out activities related to Biotechnology in Spain have been identified. The turnover of these companies exceeds 22,500 million euros and employ more than 88,100 people.